Introduction:
The biologics industry in the United States continues to thrive, with patient advocacy groups playing a crucial role in supporting patients and their families. As of 2026, the landscape of patient advocacy groups has evolved, with some emerging as key players in the industry. In the United States, there are several top biologics patient advocacy groups that are making a significant impact on the healthcare sector. Let’s take a look at the top 10 biologics patient advocacy groups in the United States in 2026.
Top 10 Biologics Patient Advocacy Groups in United States 2026:
1. American Autoimmune Related Diseases Association (AARDA)
– AARDA represents over 50 million Americans suffering from autoimmune diseases.
2. National Psoriasis Foundation
– The National Psoriasis Foundation provides support for the 8 million Americans living with psoriasis.
3. Crohn’s & Colitis Foundation
– The Crohn’s & Colitis Foundation supports the 3 million Americans living with inflammatory bowel diseases.
4. Cystic Fibrosis Foundation
– The Cystic Fibrosis Foundation is dedicated to finding a cure for cystic fibrosis, impacting over 30,000 Americans.
5. National Organization for Rare Disorders (NORD)
– NORD represents individuals with rare diseases, with over 25 million Americans affected by rare conditions.
6. Lupus Foundation of America
– The Lupus Foundation of America supports the 1.5 million Americans living with lupus.
7. American Cancer Society
– The American Cancer Society is a leading organization in the fight against cancer, impacting millions of Americans.
8. Muscular Dystrophy Association (MDA)
– The MDA supports individuals with muscular dystrophy and related diseases, impacting over 250,000 Americans.
9. Leukemia & Lymphoma Society
– The Leukemia & Lymphoma Society is dedicated to supporting individuals with blood cancers, impacting over 1.3 million Americans.
10. Alzheimer’s Association
– The Alzheimer’s Association provides support for individuals with Alzheimer’s disease, impacting over 6 million Americans.
Insights:
The role of patient advocacy groups in the biologics industry is becoming increasingly important, with these organizations providing crucial support and resources to patients and their families. As the prevalence of chronic diseases continues to rise in the United States, patient advocacy groups will play a key role in advocating for improved access to biologics and innovative treatments. In 2026, it is expected that these advocacy groups will continue to drive awareness and support for patients, ultimately shaping the future of healthcare in the United States.
Related Analysis: View Previous Industry Report
